RT Journal Article
SR Electronic
T1 A Possible Role of Interleukin-18 Binding Protein in Immune Regulation of Postoperative Pain: A Prospective Randomized Clinical Trial
JF Anticancer Research
JO Anticancer Res
FD International Institute of Anticancer Research
SP 3113
OP 3119
DO 10.21873/anticanres.16483
VO 43
IS 7
A1 ESKELINEN, MAARET
A1 SAIMANEN, IINA
A1 PULKKINEN, JUKKA
A1 SELANDER, TUOMAS
A1 HOLOPAINEN, ANU
A1 HÄMÄLÄINEN, ESA
A1 ESKELINEN, MATTI
YR 2023
UL http://ar.iiarjournals.org/content/43/7/3113.abstract
AB Background/Aim: A possible role of interleukin-18 binding protein (IL-18BP) in immune regulation of pain and analgesics following surgery is rarely studied. The aim of this study was to investigate serum IL-18BP values in a cohort of laparoscopic cholecystectomy (LC) and minilaparotomy cholecystectomy (MC) patients and to establish their relationship with other cytokines and number of analgesic doses (NAD) of LC and MC patients postoperatively. Patients and Methods: Blood levels of IL-18BP, six other interleukins (IL-18, IL-1ra, IL-6, IL-10, IL-1β, and IL-8) and high-sensitivity C-reactive protein were measured before operation (PRE), immediately after operation (POP1), and six hours after operation (POP2) in 114 patients with cholelithiasis. Results: Following surgery, the mean serum IL-18BP values correlated significantly to numeric rating scale (NRS) pain scores at 24 hours (r=0.194, p=0.009). In addition, the mean serum IL-18BP values correlated significantly to NAD (r=0.254, p<0.001). Conclusion: IL-18BP, a soluble antagonist of IL-18, correlates to NRS and NAD in LC and MC patients, which may support a possible role of IL-18BP in immune regulation of postoperative pain.